Efonidipine
- Level
- Commodity
- Parent
- 51433900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433901This classification denotes a calcium channel blocker with the molecular formula C34H38N3O7P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40ZTP2T37Q, chemically known as 2-(n-benzylanilino)ethyl (- )-1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-5-phosphononicotinate, cyclic 2,2-dimethyltrimethylene ester. but generally known as efonidipine, which bears US NIH Compound Identifier 119171. European Medicines Agency schedules Efonidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06471MIG. The term EFONIDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). EFONIDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule efonidipine under HS 29349990 and SITC 51579. As of Q4 2014, EFONIDIPINE remains the US FDA Preferred Term for this commodity. Efonidipine bears US NLM identifiers UMLS ID C0286819 and NCI Concept Code C73026. SMILES: P1(=O)(OCC(CO1)(C)C)C1=C(NC(=C(C1c1cc([N](=O)O)ccc1)C(=O)OCCN(Cc1ccccc1)c1ccccc1)C)C.
Same parent
Under 51433900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.